Abstract

The soluble epoxide hydrolase (sEH) enzyme is a major regulator of bioactive lipids. The enzyme is highly expressed in liver and kidney and modulates levels of endogenous epoxy-fatty acids, which have pleiotropic biological effects including limiting inflammation, neuroinflammation, and hypertension. It has been hypothesized that inhibiting sEH has beneficial effects on limiting obesity and metabolic disease as well. There is a body of literature published on these effects, but typically only male subjects have been included. Here, we investigate the role of sEH in both male and female mice and use a global sEH knockout mouse model to compare the effects of diet and diet-induced obesity. The results demonstrate that sEH activity in the liver is modulated by high-fat diets more in male than in female mice. In addition, we characterized the sEH activity in high fat content tissues and demonstrated the influence of diet on levels of bioactive epoxy-fatty acids. The sEH KO animals had generally increased epoxy-fatty acids compared to wild-type mice but gained less body weight on higher-fat diets. Generally, proinflammatory prostaglandins and triglycerides were also lower in livers of sEH KO mice fed HFD. Thus, sEH activity, prostaglandins, and triglycerides increase in male mice on high-fat diet but are all limited by sEH ablation. Additionally, these changes also occur in female mice though at a different magnitude and are also improved by knockout of the sEH enzyme.

Highlights

  • The soluble epoxide hydrolase enzyme plays a role in physiology and pathophysiology by regulating several classes of bioactive lipids, epoxy-fatty acids (EpFA), which are rapidly hydrolyzed by the sEH

  • We investigated brown adipose tissue (BAT) and observed a higher overall sEH activity level in BAT compared to white adipose tissue (WAT) across diet groups present in both females and males

  • The sEH activity appeared to correlate with the different diet treatments across groups in WT mice

Read more

Summary

Introduction

The soluble epoxide hydrolase (sEH) enzyme plays a role in physiology and pathophysiology by regulating several classes of bioactive lipids, epoxy-fatty acids (EpFA), which are rapidly hydrolyzed by the sEH. There have been several indications that this enzyme has a role in metabolic disease and obesity (Anandan et al, 2011; Luria et al, 2011; Overby et al, 2020). A high-fat diet (HFD) is known to alter the microbiome and GI tract cancers where sEH plays a role (Zhang et al, 2013b; Wang et al, 2017) and substitutions with omega 3 fatty acids can have significant effects (Zhang et al, 2013a). Inhibiting the sEH with smallmolecule inhibitors (sEHI) has been found to promote brown adipogenesis and reduce triglycerides in preclinical obesity (Overby et al, 2020). There is a demonstrated sexual dimorphism in sEH activity and expression

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.